Editorial Team

Co-Editors-in-Chief:

Qianben Wang, PhD, Duke University, USA

Jindan Yu, MD/PhD, Emory University, USA

Deputy Editor-in-Chief: Xiaoqi Liu, PhD, University of Kentucky Cancer Biology, USA

Editorial Office Director: Benyi Li, MD/PhD, University of Kansas Medical Center, USA

Editorial office address: KU Medical Center – Kansas City, 3901 Rainbow Blvd, WHE 1020D, Kansas City, KS 66160

Phone: 9135884773; email: serican.academy@gmail.com

Executive Board Members:

Jiaoti Huang, MD/PhD; Duke University, USA

Zhou Wang, PhD; University of Pittsburgh, USA

Allen Gao, MD/PhD; University of California at Davis, USA

Jingtang Dong, PhD; Southern University of Science and Technology, China

Haojie Huang, PhD; Zhejiang University, China

Weiqiang Gao, PhD;  Shanghai Jiaotong University, China

Dean Tang, PhD; Roswell Park Comprehensive Cancer Center, USA

Zongbing You, MD/PhD, Tulane University, USA

Section Editors:

Bioinformatics & Big Data Sciences: Jonathan Zhao, MD, Emory University, Atlanta, USA

Clinical Sciences: Jun Pang, MD/PhD, Sun Yat-sen University, Shenzhen, China

Microbiology: Jianming Qiu, PhD, KUMC, Kansas City, USA

Breast Health: Xiaoming Xie, MD/PhD, Sun Yat-sen University, Guangzhou, China

Kidney Diseases: Huafeng Liu, MD/PhD, Guangdong Medical University, Zhanjiang, China

Renal Cancers: Qing Zhang, PhD, UT Southwestern Medical Center, Dallas, USA

Bladder Cancers: Chongxian Pan, PhD, Harvard University, Boston, USA

Epigenetics & Lineage Plasticity: Qi Cao, PhD, Northwestern University, Chicago, USA

Drug Discovery & Delivery: Xuesen Dong, PhD, University of British Columbia, Canada

Theranostics & Molecular Imaging: Xiankai Sun, PhD, UTSW Medical Center, Dallas, USA

Cancer Immunology: Binzhi Qian, PhD, Fudan University, Shanghai, China

DNA Damage & Repair: Wentao Li, PhD, University of Georgia, Athens, USA

Reproduction & Infertility, Qiuyang Zhang, MD/PhD, Tulane University, New Orleans, USA

Cancer Metabolism, Jianhua Xiong, PhD, Emory University, Atlanta, USA

Animal Models, Ming Chen, PhD, Duke University, Durham, USA

Experimental Therapeutics, Qi Chen, PhD, KUMC Pharmacology, Kansas City, USA

Stem Cell Signaling in prostate cancer, Xiuping Yu, PhD, LSU Health Shreveport, USA

Viral Oncoloogy, Xuefeng Liu, MD/PhD, OSU Pathology, Columbus, USA 

Cancer Targeted Therapy, Runhua Liu, PhD, UAB Genetics & Cancer Center, Birmingham, USA

Alternative Medicine, Aidong Yang, MD/PhD, Shanghai University of Traditional Chinese Medicine, China

Editorial Board Members:

Jinghui Liu, PhD, Cancer biology, University of Kentucky

Qiou Wei, PhD, Cancer Therapeutics, University of Kentucky

Ling Cai, PhD, Cancer Epigenetics, Duke University

Dingxiao Zhang, PhD, Benign Urological Diseases, Hunan University

David Zhang, MD/PhD, Pathology, New York University

Zongwei Wang, PhD, Benign Urological Diseases, Harvard University

Weimin Ci, PhD,  Bladder Biology, PLA General Hospital

Xiong Li, MD/PhD, Prostate Cancer, Guangdong Pharmaceutical University

Xiongbing Lu, MD/PhD, Urological Surgery, Nanchang University

Haixia Xu, MD/PhD, Medical Oncology, Shenzhen University

Li Liu, PhD, Molecular Imaging, UTSW Medical Center

Zhiping Wang, MD/PhD, Bladder Cancer, Lanzhou University

Bin Liu, PhD, LIver Cancer, Guangdong Medical University

Jiang Zhao, MD/PhD, Urological Oncology, Guangdong Medical University

Benkang Shi, MD/PhD, Urological Surgery, Shandong University

Yuelong Chai, MD/PhD, Plastic Surgery, Guangdong Medical University

Ka-wong Fong, PhD, Cancer Biology, University of Kentucky

Zhiguo Li, PhD, Cancer Therapeutics, University of Kentucky

Lei Li, MD/PhD, Urological Surgery, Xi’An Jiaotong University

Qi Ma, MD/PhD, Medical Oncology, Ningbo University

Wang, Liu, PhD, Prostate Cancer, KUMC Urology

Shun Wang, MD/PhD, Shanghai University of Traditional Chinese Medicine